1 | personalized healthcare services such | | | | | | | 3 | 0.41% |
2 | most during and after | | | | | | | 3 | 0.41% |
3 | delivering multidimensional quality of | | | | | | | 3 | 0.41% |
4 | different cancer life champions | | | | | | | 3 | 0.41% |
5 | prefrail and frail cancer | | | | | | | 3 | 0.41% |
6 | a timely and more | | | | | | | 3 | 0.41% |
7 | decision support at the | | | | | | | 3 | 0.41% |
8 | the most during and | | | | | | | 3 | 0.41% |
9 | timely and more accurate | | | | | | | 3 | 0.41% |
10 | healthcare services such as | | | | | | | 3 | 0.41% |
11 | services such as symptom | | | | | | | 3 | 0.41% |
12 | and after their treatment | | | | | | | 2 | 0.28% |
13 | patients as well as | | | | | | | 2 | 0.28% |
14 | older prefrail and frail | | | | | | | 2 | 0.28% |
15 | a health recommender system | | | | | | | 2 | 0.28% |
16 | and frail cancer patients | | | | | | | 2 | 0.28% |
17 | frail cancer patients as | | | | | | | 2 | 0.28% |
18 | cancer patients as well | | | | | | | 2 | 0.28% |
19 | well as their caregivers | | | | | | | 2 | 0.28% |
20 | as well as their | | | | | | | 2 | 0.28% |
21 | providing support to aged | | | | | | | 2 | 0.28% |
22 | healthcare professionals with an | | | | | | | 2 | 0.28% |
23 | professionals with an integrated | | | | | | | 2 | 0.28% |
24 | with an integrated big | | | | | | | 2 | 0.28% |
25 | an integrated big datadriven | | | | | | | 2 | 0.28% |
26 | support to aged and | | | | | | | 2 | 0.28% |
27 | lifechamps is providing support | | | | | | | 2 | 0.28% |
28 | is providing support to | | | | | | | 2 | 0.28% |
29 | to improve their qol | | | | | | | 2 | 0.28% |
30 | treatments lifechamps is providing | | | | | | | 2 | 0.28% |
31 | their treatments lifechamps is | | | | | | | 2 | 0.28% |
32 | during and after their | | | | | | | 2 | 0.28% |
33 | life champions during and | | | | | | | 2 | 0.28% |
34 | cancer life champions during | | | | | | | 2 | 0.28% |
35 | health recommender system lifechamps | | | | | | | 2 | 0.28% |
36 | the different cancer life | | | | | | | 2 | 0.28% |
37 | all the different cancer | | | | | | | 2 | 0.28% |
38 | to all the different | | | | | | | 2 | 0.28% |
39 | support to all the | | | | | | | 2 | 0.28% |
40 | capable of delivering multidimensional | | | | | | | 2 | 0.28% |